Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ware Branch

Showing results (101-110 of 152) with videos related to

Pageof 16
Sort By:
Blood Advances|October 18, 2021
Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trialScott C Woller, Scott M Stevens, David Kaplan, et al.
Lupus|August 3, 2017
Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune diseaseD Erkan, O Unlu, S Sciascia, et al.
Journal of Reproductive Immunology|May 5, 2010
Antiphospholipid antibodies and pregnancy outcomes in women heterozygous for factor V LeidenTracy Manuck, D Ware Branch, Yinglei Lai, et al.
Arthritis Research & Therapy|March 20, 2020
Low frequency of flares during pregnancy and post-partum in stable lupus patientsJulia Davis-Porada, Mimi Y Kim, Marta M Guerra, et al.
Lupus Science & Medicine|February 3, 2016
Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study resultsCecile M Yelnik, Carl A Laskin, T Flint Porter, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 15, 2015
Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome: Study Rationale and Design (ASTRO-APS)Scott C Woller, Scott M Stevens, David A Kaplan, et al.
Obstetrics and Gynecology|October 6, 2022
Prophylactic Ureteral Stent Placement and Urinary Injury During Hysterectomy for Placenta Accreta SpectrumMorgan A Scaglione, Amanda A Allshouse, Dana R Canfield, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2016
Brief Report: Changes in Antiphospholipid Antibody Titers During Pregnancy: Effects on Pregnancy OutcomesCecile M Yelnik, T Flint Porter, D Ware Branch, et al.
Autoimmunity Reviews|January 3, 2024
Deciphering the clinical significance of longitudinal antiphospholipid antibody titersCecilia B Chighizola, Rohan Willis, Gabriella Maioli, et al.
Annals of the Rheumatic Diseases|January 27, 2018
Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodiesMimi Y Kim, Marta M Guerra, Elianna Kaplowitz, et al.
Pageof 16

Showing results (101-110 of 152) with videos related to

Sort By:
Pageof 16
Blood Advances|October 18, 2021
Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trialScott C Woller, Scott M Stevens, David Kaplan, et al.
Lupus|August 3, 2017
Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune diseaseD Erkan, O Unlu, S Sciascia, et al.
Journal of Reproductive Immunology|May 5, 2010
Antiphospholipid antibodies and pregnancy outcomes in women heterozygous for factor V LeidenTracy Manuck, D Ware Branch, Yinglei Lai, et al.
Arthritis Research & Therapy|March 20, 2020
Low frequency of flares during pregnancy and post-partum in stable lupus patientsJulia Davis-Porada, Mimi Y Kim, Marta M Guerra, et al.
Lupus Science & Medicine|February 3, 2016
Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study resultsCecile M Yelnik, Carl A Laskin, T Flint Porter, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 15, 2015
Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome: Study Rationale and Design (ASTRO-APS)Scott C Woller, Scott M Stevens, David A Kaplan, et al.
Obstetrics and Gynecology|October 6, 2022
Prophylactic Ureteral Stent Placement and Urinary Injury During Hysterectomy for Placenta Accreta SpectrumMorgan A Scaglione, Amanda A Allshouse, Dana R Canfield, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2016
Brief Report: Changes in Antiphospholipid Antibody Titers During Pregnancy: Effects on Pregnancy OutcomesCecile M Yelnik, T Flint Porter, D Ware Branch, et al.
Autoimmunity Reviews|January 3, 2024
Deciphering the clinical significance of longitudinal antiphospholipid antibody titersCecilia B Chighizola, Rohan Willis, Gabriella Maioli, et al.
Annals of the Rheumatic Diseases|January 27, 2018
Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodiesMimi Y Kim, Marta M Guerra, Elianna Kaplowitz, et al.
Pageof 16